Introduction
Enterobacteriaceae are a large family of Gram negative aerobic or facultative anaerobic oxidase negative bacteria that naturally occupy the intestinal tract of human and animals. Under certain instances, some of this enteric normal flora incidentally causes diseases such as surgical site infections (SSI) while few others are regularly pathogenic to human.
In recent years, there have been the emergence and spread of genes coding for multi-drug resistance such as extended spectrum β-lactamases (ESBL), AmpC β-lactamases, K1 β-lactamases, Klebsiella pneumoniae carbapenemases (KPC) and metallo-β-lactamases among Enterobacteriaceae and other Gram negative organisms. These β-lactamases confer resistance to most penicillins, cephalosporins and carbapenems. Many of these genes are plasmid mediated which has ensured their transfer and wide spread to many genera of bacteria in many parts of the world resulting in several outbreaks [1, 2, 3 ] .
ESBLs are one of the most common mechanisms of antimicrobial resistance which has spread threateningly to many parts of the world [4, 5, 6] . These mutant plasmid mediated β-lactamases confer resistance to all first and second generation cephalosporins as well as the extended spectrum (third generation) cephalosporins. The plasmids can be transferred to other strains and species of bacteria as a result of which the coded antibiotic resistance continue to spread [7] . With Escherichia coli being the most abundant specie of Enterobacteriaceae in the gut, the tendency is that a single strain bearing antibiotic resistance plasmids soon transmits these to most members of the family in the habitat. Widespread use of third generation cephalosporins is believed to be the major driving force for the mutations that culminate in the emergence of ESBL production from the original TEM1, TEM2 and SHV1 cephalosporin susceptible β-lactamases in the Enterobacteriaceae family [8] . ESBL-producing organisms have also been identified with multidrug resistance to other classes of antibiotics such as aminoglycosides, ampicillins [ 9, 10] cotrimoxazole, tetracyclines and fluoroquinolones [11] thus, further narrowing therapeutic options to few expensive antibiotics that are neither readily available nor affordable to most patients in resource poor countries.
In surgical patients, these organisms can cause serious complications such as surgical sites infections, urinary tract infection, catheter associated urinary tract infections, venous catheter infections and others with consequent septicaemia. Routine antibiotic susceptibility testing to this emerging resistance is yet to be popular in low resource settings of the world probably due to extra operational cost, time, as well as dearth of skilled manpower. The out-come thus are therapeutic failure, prolonged hospital stay, economic losses and sometimes death [12] . The continuous spread of these resistant mutants if unchecked, regrettably, portends a gradual return to the pre-antibiotic era.
In Nigeria, except for a few studies in the West [1, 13] and East [14] data on the spread of these organisms is still sparse. There is therefore a paucity of data on these organisms in several parts of the country. Continuous tracking is necessary to guide rational antibiotic prophylaxis and post-operative antimicrobial intervention.
This study is aimed at defining the intestinal colonization rate of Enterobacteriaceae bearing ESBL resistance genes in surgical patients in University of Calabar Teaching Hospital using Esherichia coli as surrogate. This is necessary as part of the hospital infection control strategies toward developing a good antibiotic stewardship program.
II.
Subjects and Methods: 
Sample collection and processing:
A preformed interviewer administered questionnaire was used to collect necessary data about patient's demographics, clinical diagnosis, surgical procedure, prophylactic antibiotics, post-operative antibiotics and co-morbidity. Rectal swabs were collected from consenting patients in the ward, before surgery or within 48 hours post-surgery for surgical emergencies. Swabs were collected by inserting cotton wool swab sticks about 2.5cm beyond the anal sphincter and rotated gently through the crypts. The swabs were inoculated on McConkey agar (Lab-M Ltd, Lancashire, UK) and incubated for 18hours at 37 o C aerobically. Escherichia coli were identified using morphologic characteristics, lactose fermentation, motility and indole production. The Antimicrobial susceptibility patterns of the isolates were determined using the Modified Kirby-Bauer disc diffusion method according to the Clinical and Laboratory Standard Institute (CSLI) guidelines [15] . Mueller Hinton agar (Lab-M Ltd Lancashire, UK) and Oxoid antibiotics discs (Oxoid Ltd, Cambridge, UK) were used. E. coli isolates with 30µg ceftriaxone disc zone of inhibition ≤27mm and 30µg ceftazidime disc zone ≤22mm were suspected to be ESBL producing and subjected to Double Disc Synergy ESBL confirmatory test [16] as demonstrated in Figure 1 . Morphologic classification of ESBL to either the CTX-M or TEM/SHV types was made if it was detected by either cefotaxime or ceftazidime respectively [16] .
Quality controls:
American Type Culture Collection (ATCC) 25922 Escherichia coli was used as susceptibility test control and ESBL negative control. Locally isolated ESBL producing E. coli designated AFU11 was used as ESBL positive control.
Data analysis:
All data were analyzed using Statistical Package for Social Sciences (SPSS) version 19.0 (SPSS Inc. Chicago, USA). All data were categorical and presented as % (n/sample size). Pearson's correlations and Chi square test were used to evaluate relationships. All P-values were 2-sided and a P-value ≤0.05 was considered to be statistically significant.
III.
Results:
A Total of 192 patients were enrolled into the study. Surgical procedures performed on the patients included: Abdomino-pelvic resection of colorectal Cancer (n=1), Uterine Adhesiolysis(n=4), Appendectomy(n=15), Orchidopexy (n=2), Excision biopsy(n=25), Excision of cystic hygroma (n=2), Examination under anaesthesia(n=2), Hydrocoelectomy(n=6), Haemorhoidectomy(n=3), Herniorhaphy/herniotomy(n=73), Laparotomy(n=22), nephrolitotomy(n=2), Open reduction and internal Fixation (n=2), Prostatectomy(n=3), Parathyroidectomy (n=1), Posterior urethral valve excision(n=2), Urethroplasty(n=2), Hystero-Salpingography(n=2), Caesarian section(n=18), Total Abdominal hysterectomy(n=6).
The prophylactic antibiotic prescription pattern is as shown in Table 1 . A Total of 67.7% (130/192) of the patients received a prophylactic antibiotic which was continued for a minimum of five days after surgery. All the patients who did not receive any antibiotic were in the paediatric subgroup (88.6% (62/70)). Ceftriaxone was the most favoured antibiotic. It was used in combination with metronidazole in 63.1% (82/130) and alone in 7.7% (10/130) of the cases.
Antimicrobial susceptibility of the rectal E. coli isolates revealed that 39.6% (76/192) were resistant and 3.1% (6/192) Table 2) .
Comparison of susceptibility of ESBL positive and negative isolates to other classes of antimicrobials (Table 3) showed that all isolates were susceptible to Meropenem. ESBL positive isolates were more likely to be resistant to Gentamicin (χ2=15.190;df=2;P=0.001), Ciprofloxacin (χ2=35.829;df=2;P<0.0001) and Cotrimoxazole (χ2=9.229;df=1;P=0.001). A higher level of resistance to Amoxicillin-clavulanate 57.8% was observed amongst the ESBL-positive organisms however, there was no statistically significant difference between the ESBL positive and negative (47.1%) group (χ2=3.743;df=2;P=0.154) ( Table 3) Younger patients were more likely to be colonized as they was a negative correlation between age and ESBL colonization which was statistically significant (Pearson's correlation = -0.196; P=0.006). None of the patients older than 60 years was colonized while patients less than 9 years were more preponderant ( Figure. 2).
Evaluation of prophylactic antibiotic coverage of the patients bearing rectal ESBL showed that 50.0% (26/52) received ceftriaxone with or without metronidazole, 38.5% (20/52) which were also all of the colonized, paediatrics patients had no antibiotics while cefuroxime alone, cefuroxime with metronidazole and ofloxacin alone were given to 3.8% (2/52) of patients each.
IV.

Discussion:
This study evaluated the rate of ESBL colonization of surgical patients in the University of Calabar Teaching Hospital using Escherichia coli as surrogate organism. E. coli was used because it is the most predominant Enterobacteriaceae in the gut and therefore the most likely to be transferred from the gut to other sites or to other patients. The 27.1% rectal ESBL carriage rate recorded in this work is similar to 22.1% recorded amongst paediatric patients on first day of hospitalization in Madagascar [17] and 26.8% in Buenos Aires, Argentina [18] but relatively lower than 32% among clinical isolates reported in India [5] . Since this resistance mechanism is plasmid mediated, there is a tendency for its spread in the community and more especially in hospital settings. This will further undermine the usefulness of third generation cephalosporins, several penicillins as well as other classes of antibiotics such as aminoglycosides, quinolones, sulfamethoxazole/trimethoprim due to co-resistance as was observed here and have also been reported elsewhere [9, 10, 11] . The other resistance mechanisms which may have accounted for the remaining 50% of non ESBL resistance to third generation cephalosporins may have been plasmid or chromosomal ampC and K1 β-lactamases. Apart from chromosomal ampC, the others are also plasmid mediated and thus could be transferred from one Enterobacteriaceae to another thereby compounding the problem of antibiotic resistance. Most chromosomal ampC bearing Enterobacteriaceae may also carry ESBL resistance mechanisms which will require the demonstration of clavulanic effect with cefepime and resistance to cefoxitin [16] which were not available to us at time of study. The failure of routine susceptibility testing techniques to include testing for ESBL and other resistance mechanisms in Enterobacteriaceae may lead to poor surgical outcome with increased morbidity and possibly mortality.
The relative predominance of the CTX-M subtypes of ESBL(30.8%) obtained in this study is similar to values of 29.3-50.6% recorded in Thailand [19] but significantly different from value of 11.3% obtained in Birmingham, UK [ 20] . CTX-M ESBL genotype is tending towards a global pandemic, with intercontinental travel as a major enhancing factor [21] . Nigeria enjoys rich medical tourism with India, one of the countries with high ESBL carriage rate with a predominance of CTX-M genotypes [5] .
There was a higher propensity for an ESBL producing isolate to be resistant to other classes of antimicrobials such as the quinolones (57.7%) and aminoglycoside (26.9%). These findings are similar to values of 40% for a quinolone and 14% for an aminoglycoside from a study in Morocco [22] . Empirical treatment options for these organisms are therefore limited. Treatment of ESBL producing organisms with antibiotics to which they are resistant will lead to treatment failure, waste of finances and high mortality.
It was observed in this study that most adult patients received prophylactic antibiotics administered before surgery and continued empirically till about the 5 th post-operative day. Evaluation of prescription pattern showed a higher use in adult surgeries than paediatric surgeries. There was the highest proclivity towards cephalosporins particularly ceftriaxone. Since surgical sites infections are more likely to originate from patients flora, the high level of resistance to cephalosporins by rectal E. coli observed in this study means their prophylactic use and inappropriate empirical use in this patients would not have been of any clinical benefit. With the plasmid mediated spread of ESBL and other β-Lactamase resistance mechanisms [10] , the usefulness of this antibiotics is bound to get worse with the coming decades. The high rate of resistance to cephalosporins which are most predominantly prescribed for surgical prophylaxis further selects for mutants thus drive emergence of antibiotic resistance.
Established risk factors for ESBL colonization are previous hospital admission or visit and cephalosporin use [23] . The correlation of ESBL colonization with younger age observed in this study had also been observed elsewhere [24, 25] . Among infants and the very young with no history of previous hospital admissions and cephalosporin use observed in this study, colonization most probably originated from maternal or environmental flora [26] . Several studies have shown that the feacal colonization of newborns with ESBLproducing organisms take origin from maternal vagina during delivery with subsequent spread to care-givers and the environment [27, 28] .
V. Conclusion
This study has shown that there is a circulating pool of ESBL in several patients seeking care in the hospital. ESBL colonization of children may result in horizontal spread among peers, with risk of outbreaks in paediatric wards. High impact intervention strategies recommend routine screening of surgical patients preoperatively for Methicillin Resistant Staphylococcus aureus (MRSA) [29] . With the high prevalence of ESBL observed in this study and many others, [5, 17, 18] a pre-surgery rectal screening for ESBL as well as other resistance mechanisms such as ampC, and K1 β-lactamases, is therefore imperative. Patients with pan-resistant isolates could also be evaluated for carbapenamases such as KPC and metallo-β-lactamases. This will provide ground for high index of suspicion, guide rational prophylaxis and empirical therapy since most health-care associated infections in surgical patients usually emanate from patient own flora [30] . In Nigeria, although there are regulations on antibiotics procurement and administration, there are rarely enforced. All brands of antibiotics can be purchased over the counter and in market places. Community abuse of antibiotics and irrational hospital use as evident in this study accounts for the high carriage rate of ESBL and antibiotic resistance recorded in this study. This is also buttressed by the 100% susceptibility still observed for Meropenem in this setting. Carbapenems are new entrants into the market. They are still relatively expensive and only injectable forms are available which makes community abuse less likely. However, irrational use in healthcare facilities and import of metallo β-lactamases through medical tourism may soon drive resistance. Continuous monitoring, formulary restriction, functional antibiotic stewardship programmes and strict regulations as has been demonstrated elsewhere [31] will therefore be necessary to curtail this gradual slip into the pre-antibiotic era.
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